News

Geron Corp. quits stem cell work

 

The Menlo Park-based biotechnology firm Geron Corp. announced recently that it was abandoning its stem cell research in favor of focusing on two cancer drugs.

The motivation appears financial, according to a statement issued by the company.

"The decision to narrow Geron's technology and therapeutic focus was made after a strategic review of the costs, value inflection timelines and clinical, manufacturing and regulatory complexities," the company said.

As a result, 66 jobs -- 38 percent of its workforce -- will be eliminated, the company said.

The news came as a blow to those hoping to benefit from stem cell therapy, a field that held promise for those paralyzed by spinal cord injuries.

Stem cells possess the ability to become any other type of cell in the body, leading Geron's scientists to explore how to grow the cells into replacement neurons that could reverse paralysis.

Comments

Sorry, but further commenting on this topic has been closed.

Mountain View: French bakery to replace Drunken Lobster
By Elena Kadvany | 3 comments | 2,338 views

A New Way to Think About High Speed Rail
By Steve Levy | 10 comments | 1,493 views

Sweet Potato Canapé and Food Party! Holiday Favorites
By Laura Stec | 0 comments | 856 views

Twenty Years in the Sixties: How an Alcoholic Hippie Became a Self-Giving Servant
By Aldis Petriceks | 0 comments | 835 views

Couples: Slowing Down & Content and Process Conversation
By Chandrama Anderson | 0 comments | 764 views

 

The holidays are here!

From live music to a visit with Santa, here's a look at some local holiday activities to help you get into the spirit of the season.

VIEW